Treatment of Post-Punch Biopsy Bleeding in Apixaban-Treated Patients Using Self-Administered BXP154B
Phase 2
Completed
- Conditions
- Wound Bleeding
- Interventions
- Drug: BXP154BDrug: PlaceboProcedure: Punch Biopsy
- First Posted Date
- 2024-01-16
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Bio 54, LLC
- Target Recruit Count
- 24
- Registration Number
- NCT06205615
- Locations
- 🇺🇸
Accel Research Sites Network - DeLand, DeLand, Florida, United States
Treatment of Post-Punch Biopsy Bleeding in Anticoagulated Patients Using Self-Administered BXP154
- First Posted Date
- 2023-05-01
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Bio 54, LLC
- Target Recruit Count
- 24
- Registration Number
- NCT05837338
- Locations
- 🇺🇸
Accel Research Sites Network - DeLand, DeLand, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath